Ramesh Vidavalur
Overview
Explore the profile of Ramesh Vidavalur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vidavalur R, Bhutani V
Semin Fetal Neonatal Med
. 2025 Mar;
:101620.
PMID: 40044506
Hemolytic disorders in neonates, once exceedingly common causes of infant mortality, have become increasingly rare and now largely non-fatal. Global advancements in neonatal care and deeper understanding of the mechanisms...
2.
Vidavalur R, Schettler K, Dani C, Fouzas S, Mimoso G, Sanchez-Luna M, et al.
Pediatr Res
. 2025 Feb;
PMID: 39900836
No abstract available.
3.
Vidavalur R, Schettler K, Dani C, Fouzas S, Mimoso G, Sanchez-Luna M, et al.
Pediatr Res
. 2024 Nov;
PMID: 39543402
Background: Limited data exist on population-level mortality outcomes related to extreme neonatal hyperbilirubinemia (EHB) and this study examines trends in annual infant mortality rate (IMR) attributed to hemolytic and perinatal...
4.
Vidavalur R, More K, Bhutani V
Semin Fetal Neonatal Med
. 2024 Nov;
29(6):101560.
PMID: 39537453
Neonatal encephalopathy (NE) is a significant cause of neonatal mortality in low- and middle-income (LAMI) countries, with far-reaching impacts on families and national human capital. Quantifying the disease burden in...
5.
Vidavalur R, Bhutani V
Indian J Pediatr
. 2024 Aug;
91(12):1262-1267.
PMID: 39167302
Prevention of neonatal bilirubin injury exemplifies success of systems approach to avert adverse neonatal and childhood outcomes that rely on strategies including prenatal identification of Rhesus sensitization, universal maternal blood...
6.
Bhutani V, Vidavalur R, Wong R
J Perinatol
. 2024 Feb;
44(4):600-601.
PMID: 38383576
No abstract available.
7.
Bhutani V, Vidavalur R, Wong R
J Perinatol
. 2023 Dec;
44(4):493-500.
PMID: 38151598
Objective: Initiatives, "Every Newborn Action Plans" and "Sustainable Developmental Goals," are profoundly shaping global infant mortality trends. Concurrently, professional organizations recommended curricula to prevent extreme hyperbilirubinemia (EHB) sequelae. Therefore we...
8.
Vidavalur R, Bhutani V
Arch Dis Child Fetal Neonatal Ed
. 2023 Sep;
109(5):569-570.
PMID: 37734928
No abstract available.
9.
Vidavalur R, Bhutani V
Am J Perinatol
. 2023 Apr;
41(S 01):e1841-e1849.
PMID: 37105226
Objective: Glucose-6-phosphate dehydrogenase deficiency (G6PDd) is the most common inherited enzyme deficiency disorder worldwide and a major risk factor for the development of severe hyperbilirubinemia. Racial diversity of phenotypes and...
10.
Vidavalur R, Hussain N
Am J Perinatol
. 2023 Mar;
41(S 01):e1689-e1697.
PMID: 36963432
Objective: This study aimed to estimate national time trends of overall and statewise antibiotic utilization (AU) rates for suspected neonatal sepsis (SNS) in the United States. Study Design: In this...